Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DR26FQPU0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $97,614
Award facts
- Contract value 100% obligated
- $97,613.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $97,613.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency.
This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors for pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's PPV-G GEN V contract, awarded concurrently on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. The contractor's extensive product portfolio and demonstrated performance across specialty pharmaceuticals, biologics, and medical consumables positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQPU0?
SPE2DR26FQPU0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQPU0 worth?
The government has obligated $97,614 on SPE2DR26FQPU0.
Is contract SPE2DR26FQPU0 an order under another contract?
Yes. SPE2DR26FQPU0 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPU0 competed?
The extent of competition for SPE2DR26FQPU0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award